ClinVar Miner

Submissions for variant NM_005120.3(MED12):c.4606C>T (p.Arg1536Trp)

dbSNP: rs2092323072
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003597241 SCV002161265 uncertain significance FG syndrome 2023-05-23 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals affected with MED12-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MED12 protein function. ClinVar contains an entry for this variant (Variation ID: 1390351). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1536 of the MED12 protein (p.Arg1536Trp).
Ambry Genetics RCV004039134 SCV003651931 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2022-11-04 criteria provided, single submitter clinical testing The c.4606C>T (p.R1536W) alteration is located in exon 33 (coding exon 33) of the MED12 gene. This alteration results from a C to T substitution at nucleotide position 4606, causing the arginine (R) at amino acid position 1536 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). This alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.